Yubo Biotech Debt to Equity Ratio 2010-2024 | YBGJ
Current and historical debt to equity ratio values for Yubo Biotech (YBGJ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Yubo Biotech debt/equity for the three months ending December 31, 2024 was 0.00.
| Yubo Biotech Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.01B | $0.00B | -1.47 |
| 2024-09-30 | $0.01B | $0.00B | -1.54 |
| 2024-06-30 | $0.00B | $0.00B | -1.71 |
| 2024-03-31 | $0.00B | $0.00B | -1.75 |
| 2023-12-31 | $0.00B | $0.00B | -1.90 |
| 2023-09-30 | $0.00B | $0.00B | -2.73 |
| 2023-06-30 | $0.00B | $0.00B | -2.71 |
| 2023-03-31 | $0.00B | $0.00B | -3.52 |
| 2022-12-31 | $0.00B | $0.00B | -5.15 |
| 2022-09-30 | $0.00B | $0.00B | -6.65 |
| 2022-06-30 | $0.01B | $0.00B | -4.24 |
| 2022-03-31 | $0.01B | $0.00B | -6.88 |
| 2021-12-31 | $0.01B | $0.00B | -35.96 |
| 2021-09-30 | $0.00B | $0.00B | 18.60 |
| 2021-06-30 | $0.00B | $0.00B | 6.33 |
| 2021-03-31 | $0.00B | $0.00B | 3.22 |
| 2020-12-31 | $0.00B | $0.00B | 1.09 |
| 2020-11-30 | $0.00B | $0.00B | -1.00 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-08-31 | $0.00B | $0.00B | -1.00 |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-05-31 | $0.00B | $0.00B | -1.00 |
| 2020-03-31 | $0.00B | 0.00 | |
| 2020-02-29 | $0.00B | $0.00B | -1.00 |
| 2019-11-30 | $0.00B | $0.00B | -1.00 |
| 2019-08-31 | $0.00B | $0.00B | -1.00 |
| 2019-05-31 | $0.00B | $0.00B | -1.00 |
| 2019-02-28 | $0.00B | $0.00B | -1.00 |
| 2018-11-30 | $0.00B | $0.00B | -1.00 |
| 2018-08-31 | $0.00B | $0.00B | -1.00 |
| 2018-05-31 | $0.00B | $0.00B | -1.00 |
| 2018-02-28 | $0.00B | $0.00B | -1.00 |
| 2017-11-30 | $0.00B | $0.00B | -1.00 |
| 2017-08-31 | $0.00B | $0.00B | -1.00 |
| 2017-05-31 | $0.00B | $0.00B | -1.00 |
| 2017-02-28 | $0.00B | $0.00B | -1.00 |
| 2016-11-30 | $0.00B | $0.00B | -1.00 |
| 2016-08-31 | $0.00B | $0.00B | -1.01 |
| 2016-05-31 | $0.00B | $0.00B | -1.00 |
| 2016-02-29 | $0.00B | $0.00B | -1.01 |
| 2015-11-30 | $0.00B | $0.00B | -1.01 |
| 2015-08-31 | $0.00B | $0.00B | -1.01 |
| 2015-05-31 | $0.00B | $0.00B | -1.01 |
| 2015-02-28 | $0.00B | $0.00B | -1.01 |
| 2014-11-30 | $0.00B | $0.00B | -1.01 |
| 2014-08-31 | $0.00B | $0.00B | -1.01 |
| 2014-05-31 | $0.00B | $0.00B | -1.01 |
| 2014-02-28 | $0.00B | $0.00B | -1.01 |
| 2013-11-30 | $0.00B | $0.00B | -1.02 |
| 2013-08-31 | $0.00B | $0.00B | -1.02 |
| 2013-05-31 | $0.00B | $0.00B | -1.01 |
| 2013-02-28 | $0.00B | $0.00B | -1.02 |
| 2012-11-30 | $0.00B | $0.00B | -1.01 |
| 2012-08-31 | $0.00B | $0.00B | -1.02 |
| 2012-05-31 | $0.00B | $0.00B | -1.01 |
| 2012-02-29 | $0.00B | $0.00B | -1.01 |
| 2011-11-30 | $0.00B | $0.00B | -1.01 |
| 2011-08-31 | $0.00B | $0.00B | -1.02 |
| 2011-05-31 | $0.00B | $0.00B | -1.00 |
| 2011-02-28 | $0.00B | $0.00B | -1.01 |
| 2010-11-30 | $0.00B | $0.00B | -1.01 |
| 2010-08-31 | $0.00B | $0.00B | -1.02 |
| 2010-05-31 | $0.00B | $0.00B | -1.00 |
| 2010-02-28 | $0.00B | $0.00B | -1.02 |
| 2009-11-30 | $0.00B | $0.00B | -1.02 |
| 2009-08-31 | $0.00B | $0.00B | -1.03 |
| 2009-05-31 | $0.00B | $0.00B | -1.00 |
| 2009-02-28 | $0.00B | $0.00B | -1.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.011B | $0.000B |
| MAGNA-LAB INC. is a development stage company. Co. has developed and now markets and intends to produce the MAGNA-SLn, the first of Co.'s proposed series of anatomy specific MRI (Magnetic Resonance Imaging) products which are smaller and cost less to own, install and operate than present ``whole body`` MRI systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Alcon (ALC) | Switzerland | $47.228B | 31.39 |
| Edwards Lifesciences (EW) | United States | $43.221B | 28.34 |
| IDEXX Laboratories (IDXX) | United States | $39.544B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.32 |
| IQVIA Holdings (IQV) | United States | $25.775B | 14.44 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.518B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.22 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |